Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Current Leases (2022 - 2026)

Exagen filings provide 5 years of Current Leases readings, the most recent being $1.3 million for Q1 2026.

  • On a quarterly basis, Current Leases rose 11.71% to $1.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $1.3 million, a 11.71% increase, with the full-year FY2025 number at $1.2 million, up 11.86% from a year prior.
  • Current Leases hit $1.3 million in Q1 2026 for Exagen, up from $1.2 million in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $1.3 million in Q1 2026 to a low of $949000.0 in Q1 2022.
  • Median Current Leases over the past 5 years was $1.1 million (2023), compared with a mean of $1.1 million.
  • Biggest five-year swings in Current Leases: grew 12.96% in 2023 and later dropped 6.41% in 2024.
  • Exagen's Current Leases stood at $1.0 million in 2022, then dropped by 6.15% to $976000.0 in 2023, then increased by 12.3% to $1.1 million in 2024, then increased by 11.86% to $1.2 million in 2025, then rose by 2.69% to $1.3 million in 2026.
  • The last three reported values for Current Leases were $1.3 million (Q1 2026), $1.2 million (Q4 2025), and $1.2 million (Q3 2025) per Business Quant data.